Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 16,418 | 10,163 | 10,934 | 9,016 | 8,678 |
| Operating Income | -16,418 | -10,163 | -10,934 | -9,016 | -8,678 |
| Other Income | 1,694 | 613 | 380 | 127 | 9 |
| Pre-tax Income | -14,724 | -9,550 | -10,554 | -8,889 | -8,669 |
| Net Income Continuous | -14,724 | -9,550 | -10,554 | -8,889 | -8,669 |
| Net Income | $-14,724 | $-9,550 | $-10,554 | $-8,889 | $-8,669 |
| EPS Basic Total Ops | -0.80 | -2.91 | -3.27 | -2.86 | -3.01 |
| EPS Basic Continuous Ops | -0.80 | -2.91 | -3.27 | -2.86 | -3.01 |
| EPS Diluted Total Ops | -0.80 | -2.91 | -3.27 | -2.86 | -3.01 |
| EPS Diluted Continuous Ops | -0.80 | -2.91 | -3.27 | -2.86 | -3.01 |
| EBITDA(a) | $-16,351 | $-10,099 | $-10,874 | $-8,964 | $-8,639 |